Single-use Bioprocessing Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
During the forecast period, the single-use bioprocessing market is expected to experience a CAGR of 11.5%. The pandemic initially had a negative impact on the market due to decreased manufacturing processes and limited demand and supply of drugs. However, single-use technology (SUT) became a popular choice for pre-commercial manufacturing, including preclinical and clinical scales. As the number of COVID-19 cases increased, the demand for effective drugs and vaccines rose, leading to a surge in adoption of single-use bioprocessing systems and technology by biopharmaceutical companies. This is due to the reduced risk of contamination and sterilization tests between batches. Additionally, drug discovery using single-use technologies became a major focus for managing the pandemic. The market witnessed significant growth during the pandemic due to these factors. The market is expected to continue growing due to faster implementation, lower risk of product cross-contamination, increasing demand for biopharmaceuticals, lower costs, and lesser environmental impact of single-use bioprocessing technologies.
Get the free sample report of the Single Use Bioprocessing Market
Comments
Post a Comment